Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2016

Sep 13, 2016

30786_dirs_2016-09-12_8b8048a5-ee05-45f9-bc91-7e8e1c0b6cc9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-09-08

Reporting Person: Magni Giovanni (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-09-10 Bio-Rad A Common Stock M 400 Acquired 13055 Direct
2016-09-11 Bio-Rad A Common Stock M 740 Acquired 13795 Direct
2016-09-12 Bio-Rad A Common Stock S 438 $155.019 Disposed 13357 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-09-08 Restricted Stock Units $0 A 2000 Acquired Bio-Rad A Common Stock (2000) Direct
2016-09-08 Non-Qualified Stock Option (right to buy) $160.37 A 2000 Acquired 2026-09-08 Bio-Rad A Common Stock (2000) Direct
2016-09-10 Restricted Stock Units $0 M 400 Disposed Bio-Rad A Common Stock (400) Direct
2016-09-11 Restricted Stock Units $0 M 240 Disposed Bio-Rad A Common Stock (240) Direct
2016-09-11 Restricted Stock Units $0 M 500 Disposed Bio-Rad A Common Stock (500) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Sold by the Issuer on behalf of the Reporting Person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.0162 to $155.0209, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F5: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F6: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.

F7: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F8: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F9: The restricted stock units vest in five equal annual installments beginning September 11, 2016.